Rna Diagnostics
Latest round
- Series A
Last raised
- Jul 2024
Total raised
- $9M
Investors
- 7
About Rna Diagnostics
Founded in 2010 and headquartered in Toronto, Canada, Rna Diagnostics Inc. is dedicated to providing precise diagnostic solutions for cancer treatment.Rna Diagnostics specializes in the development and commercialization of the Veridapt DX™ predictive biomarker platform, which measures tumor response to cancer therapies. This platform offers early insights into tumor response to neoadjuvant treatment, aiding in predicting disease-free survival for solid tumor patients, particularly those with breast cancer.Rna Diagnostics generates revenue primarily through the clinical laboratory sale of its Veridapt DX™ biomarker assay. The company engages in business-to-business transactions with healthcare providers, including hospitals and oncology clinics, facilitating the use of their diagnostic platform to inform treatment strategies.In July 2024, Rna Diagnostics Inc. The company is focused on enhancing its offerings and plans to explore new markets, although specific regions have not been disclosed.
Who invested in Rna Diagnostics
7 investors across 2 rounds
See all investors in Rna Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rna Diagnostics
Who invested in Rna Diagnostics?
Rna Diagnostics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rna Diagnostics raised?
Rna Diagnostics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rna Diagnostics last raise money?
Rna Diagnostics's most recent round on record is a Series A, in Jul 2024.
What does Rna Diagnostics do?
Founded in 2010 and headquartered in Toronto, Canada, Rna Diagnostics Inc.
Where is Rna Diagnostics headquartered?
Rna Diagnostics is headquartered in Toronto, Canada.
Which VCs invest in companies like Rna Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Rna Diagnostics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Rna Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.